— Know what they know.
Not Investment Advice

BCAX NASDAQ

Bicara Therapeutics Inc. Common Stock
1W: +0.9% 1M: -11.8% 3M: +34.6% YTD: +27.2% 1Y: +38.6%
$21.68
+0.84 (+4.03%)
 
Weekly Expected Move ±5.8%
$18 $19 $20 $21 $23
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 37 · $1.2B mcap · 35M float · 1.64% daily turnover · Short 60% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-157M
Net Income
-109.0% YoY
$-117M
Free Cash Flow
-54.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-35.2%
ROA-31.5%
ROIC1181.4%

Valuation

P/E-8.3
P/B2.5
EV/EBITDA-4.7

Leverage

Debt/Equity0.00
Current Ratio14.58
Interest Cov.0.0x

Quality Scores

Piotroski F1/9
Altman Z24.32
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms